Literature DB >> 15928524

Revision total hip and total knee arthroplasty.

Janie T Best1.   

Abstract

For thousands of patients with advanced degenerative joint disease, total joint arthroplasty provides improved function, decreased pain, and the opportunity to resume a more active lifestyle (Drake, Ace, & Maale, 2002). Although hip and knee replacements are both successful interventions for degenerative joint conditions, complications may arise that require revision of the original surgery. In 1999, approximately 25,000 revisions of knee replacements (ICD Code 81.22) and 30,000 revisions of hip replacements (ICD Code 81.53) were performed in the United States (American Academy of Orthopaedic Surgeons [AAOS], 2002). Approximately 10,000 revision total hip arthroplasty procedures were performed on Medicare patients in 2000. The total cost of revision surgery, including the 10,000 total knee revision procedures performed on this same patient population during that year, exceeds USD 3 billion (Bourne, Maloney, & Wright, 2004). Descriptions of the risk factors and indications for revision total hip and total knee arthroplasty are included in this article. Nursing interventions and patient education specific to these patient populations are outlined, and a discussion of complications following revision total joint arthroplasty is included.

Entities:  

Mesh:

Year:  2005        PMID: 15928524     DOI: 10.1097/00006416-200505000-00003

Source DB:  PubMed          Journal:  Orthop Nurs        ISSN: 0744-6020            Impact factor:   0.913


  13 in total

1.  Knee replacement and Diagnosis-Related Groups (DRGs): patient classification and hospital reimbursement in 11 European countries.

Authors:  Siok Swan Tan; Pietro Chiarello; Wilm Quentin
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2013-01-18       Impact factor: 4.342

2.  Hospital volume and surgical outcomes after elective hip/knee arthroplasty: a risk-adjusted analysis of a large regional database.

Authors:  Jasvinder A Singh; C Kent Kwoh; Robert M Boudreau; Gwo-Chin Lee; Said A Ibrahim
Journal:  Arthritis Rheum       Date:  2011-08

Review 3.  Top 50 most cited articles in revision total hip arthroplasty research.

Authors:  David Constantinescu; Dylan Luxenburg; Moses Isaac Markowitz; Rami Hisham Helmi Mahmoud; Michele D'Apuzzo
Journal:  J Orthop       Date:  2022-04-14

4.  Factors influencing inpatient rehabilitation length of stay following revision hip replacements: a retrospective study.

Authors:  So-Mei Teresa Yeung; Aileen M Davis; Rajka Soric
Journal:  BMC Musculoskelet Disord       Date:  2010-10-28       Impact factor: 2.362

5.  In Vivo Efficacy of a "Smart" Antimicrobial Implant Coating.

Authors:  Alexandra I Stavrakis; Suwei Zhu; Vishal Hegde; Amanda H Loftin; Alyssa G Ashbaugh; Jared A Niska; Lloyd S Miller; Tatiana Segura; Nicholas M Bernthal
Journal:  J Bone Joint Surg Am       Date:  2016-07-20       Impact factor: 5.284

6.  Underlying diagnosis predicts patient-reported outcomes after revision total knee arthroplasty.

Authors:  Jasvinder A Singh; David G Lewallen
Journal:  Rheumatology (Oxford)       Date:  2013-11-05       Impact factor: 7.580

7.  The effect of a manual therapy knee protocol on osteoarthritic knee pain: a randomised controlled trial.

Authors:  Henry Pollard; Graham Ward; Wayne Hoskins; Katie Hardy
Journal:  J Can Chiropr Assoc       Date:  2008-12

8.  Age, gender, obesity, and depression are associated with patient-related pain and function outcome after revision total hip arthroplasty.

Authors:  Jasvinder A Singh; David Lewallen
Journal:  Clin Rheumatol       Date:  2009-08-31       Impact factor: 2.980

9.  Incidence and risk of surgical site infection after adult femoral neck fractures treated by surgery: A retrospective case-control study.

Authors:  Chenni Ji; Yanbin Zhu; Song Liu; Jia Li; Fei Zhang; Wei Chen; Yingze Zhang
Journal:  Medicine (Baltimore)       Date:  2019-03       Impact factor: 1.817

10.  Operative diagnosis for revision total hip arthroplasty is associated with patient-reported outcomes (PROs).

Authors:  Jasvinder A Singh; David G Lewallen
Journal:  BMC Musculoskelet Disord       Date:  2013-07-17       Impact factor: 2.362

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.